The distinctive patterns of capabilities accumulation and inter-firm heterogeneity: the case of the Spanish pharmaceutical industry
Pablo D'Este
Industrial and Corporate Change, 2002, vol. 11, issue 4, 847-874
Abstract:
This paper examines the extent to which systematic differences in performance across firms can be explained by the different sets of capabilities mastered by firms. Cluster analysis is used to group firms based on the degree of capability accumulation along three dimensions: manufacturing, R&D and marketing. Sixty-seven Spanish domestic pharmaceutical firms are studied, focusing on the period 1990--1997. Our findings indicate that five clusters can be identified. Firms with better performance indicators are those that manage to generate capabilities that are uncommon among competitors--particularly capabilities in product development. Copyright 2002, Oxford University Press.
Date: 2002
References: Add references at CitEc
Citations:
There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:oup:indcch:v:11:y:2002:i:4:p:847-874
Ordering information: This journal article can be ordered from
https://academic.oup.com/journals
Access Statistics for this article
Industrial and Corporate Change is currently edited by Josef Chytry
More articles in Industrial and Corporate Change from Oxford University Press and the Associazione ICC Oxford University Press, Great Clarendon Street, Oxford OX2 6DP, UK.
Bibliographic data for series maintained by Oxford University Press ().